Pro Medicus Limited (PMCUF)
OTCMKTS · Delayed Price · Currency is USD
167.00
+4.00 (2.45%)
Nov 11, 2025, 9:30 AM EST
Pro Medicus Market Cap
Pro Medicus has a market cap or net worth of $17.39 billion as of November 11, 2025. Its market cap has increased by 28.12% in one year.
Market Cap
17.39B
Enterprise Value
17.26B
Revenue
139.63M
Ranking
n/a
PE Ratio
230.25
Stock Price
$167.00
Market Cap Chart
Since October 10, 2000, Pro Medicus's market cap has increased from 75.81M to 17.39B, an increase of 22,841.47%. That is a compound annual growth rate of 24.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 17.37B | 7.39% |
| Dec 31, 2024 | 16.18B | 137.05% |
| Dec 29, 2023 | 6.82B | 73.96% |
| Dec 30, 2022 | 3.92B | -17.24% |
| Dec 31, 2021 | 4.74B | 72.56% |
| Dec 31, 2020 | 2.75B | 68.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 674.13M |
| Glass House Brands | 579.39M |
| Northwest Biotherapeutics | 374.83M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 310.80M |
| CytoDyn | 308.64M |